EGLU ((2S)-ñ-ethylglutamic acid ) is a drug that is used in neuroscience research. It was one of the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR<sub>2/3</sub>), and so has been useful in the characterization and study of this receptor subfamily.